Tracking the relevant researches of CADD drug development against COVID-19
Epigallocatechin gallate has been investigated for the treatment of Hypertension and Diabetic Nephropathy. [DrugBank]
Aryl hydrocarbon receptor (Humans); DNA (cytosine-5)-methyltransferase 1 (Humans); Dihydrofolate reductase, mitochondrial (Humans) [DrugBank]
Not Available [DrugBank]
Tips: Click on the link to jump to the 'SwissTargetPrediction' webserver. Select the species of 'Homo sapiens', and then paste the SMILES of EGCG (Epigallocatechin gallate) in the SMILES input box.
Tips: Click on the link to jump to the 'CB-Dock' webserver. Upload the structure file of target predicted by 'SwissTargetPrediction' and the 2D/3D structure file of EGCG (Epigallocatechin gallate) to perform blind docking.